Claritin is a trade name for the antihistamine medication loratadine. It is classified as a second generation antihistamine that blocks h1 receptors on eosinophils and mast cells. By antagonizing histamine it reduces the allergic inflammatory response that causes sneezing runny nose and itching. The drug is absorbed from the gastrointestinal tract and undergoes metabolism in the liver producing an active metabolite that contributes to its long lasting effect. Its pharmacokinetics involve rapid oral uptake and a half life that supports once daily dosing. The competitive inhibition of histamine at peripheral tissues leads to decreased vasodilation and mucus secretion. This blockade results in symptom relief without significant central nervous system sedation compared with earlier antihistamines. Overall Claritin provides targeted control of seasonal and perennial allergic rhinitis through selective h1 receptor antagonism.

Claritin is the brand name for the antihistamine drug loratadine used to relieve seasonal allergy symptoms. It works by blocking histamine h1 receptors in the body preventing histamine from causing inflammation and irritation. By antagonizing these receptors Claritin reduces sneezing runny nose and itchy eyes without causing significant drowsiness. The drug is absorbed orally and metabolized in the liver before being eliminated through the kidneys. Its selective action on peripheral histamine receptors allows it to treat allergy symptoms while minimizing effects on the central nervous system. This mechanism provides sustained relief from allergic rhinitis and urticaria for many users.

The most common side effects are usually mild and short lived. They often include headache fatigue nausea and mild fever. Most people notice these reactions shortly after vaccination. Serious adverse events are rare and occur less frequently. Common side effects tend to resolve within a few days. Local reactions such as soreness at the injection site are frequently reported. Systemic symptoms like muscle aches may appear after the second dose. Overall the frequency of these effects is consistent across age groups.

The most common side effects often include mild headache nausea and fatigue. These reactions are frequently observed across many populations and do not typically require intervention. Some individuals may also experience temporary dizziness or mild skin irritation. The severity of these effects can vary depending on dosage and individual sensitivity. Most occurrences are short lived and resolve without specific treatment. Monitoring for any persistent symptoms is advisable but does not imply a need for professional advice. Patients are encouraged to continue routine monitoring of their health while using the medication. Overall the profile of common side effects remains consistent in clinical observations.